SARS-CoV-2 vaccine (pan-variant) (BioNet/CEPI)

N/A

Report date: 2025/12/12 17:32:18

Base Information

Drug NameSARS-CoV-2 vaccine (pan-variant) (BioNet/CEPI)
Drug Alias Namepancoronavirus mRNA vaccine (BioNet)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAfricaThailand +[4] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBionet-Asia Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionet-Asia Co LtdUniversity Of North Carolina, GreensboroInternational Vaccine Institute +[7] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A